Prosecution Insights
Last updated: May 29, 2026

Examiner: COUGHLIN, DANIEL F

Tech Center 3700 • Art Units: 1619 3791

This examiner grants 39% of resolved cases

Performance Statistics

39.2%
Allow Rate
-30.8% vs TC avg
547
Total Applications
+20.0%
Interview Lift
1337
Avg Prosecution Days
Based on 508 resolved cases, 2023–2026

Rejection Statute Breakdown

0.2%
§101 Eligibility
12.9%
§102 Novelty
73.0%
§103 Obviousness
1.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18810822 ORTHOBIOLOGIC IMPLEMENTATION SYSTEM Non-Final OA Xenco Medical, LLC
17637022 AQUEOUS DISPERSIONS INCLUDING POLYMER PARTICLES Final Rejection NORTH CAROLINA STATE UNIVERSITY
17998374 BLONANSERIN-CONTAINING PATCH AND PRODUCTION METHOD THEREFOR Final Rejection KANEKA CORPORATION
17630052 COMPLEMENT ACTIVE FRAGMENT-LOADED THREE-DIMENSIONAL BIOMATERIAL FOR DENTAL AND/OR OTHER TISSUE REGENERATION Non-Final OA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
17382666 BONDED POWDERS FOR THE TREATMENT OF BODILY LESIONS Final Rejection Cook Medical Technologies LLC
17040190 THERMOPLASTIC MATERIALS INCORPORATING BIOACTIVE INORGANIC ADDITIVES Final Rejection Evonik Operations GmbH
17755462 CERAMIC SCAFFOLD Final Rejection University of Southern California
17623390 BIOENERGETIC COMBINATIONS AND METHODS OF USING SAME Final Rejection Conopco, Inc., d/b/a UNILEVER
17769713 TRANSDERMAL ABSORPTION-TYPE PATCH Final Rejection KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
18036203 ASENAPINE-CONTAINING PATCH Final Rejection HISAMITSU PHARMACEUTICAL CO., INC.
18035951 METHOD FOR INHIBITING ASENAPINE DEGRADATION Final Rejection HISAMITSU PHARMACEUTICAL CO., INC.
18283587 3D PRINTING BONE-REGENERATION SCAFFOLDS COMPOSED OF BIOLOGICALLY-DERIVED BONE POWDER Non-Final OA COLORADO STATE UNIVERSITY RESEARCH FOUNDATION
18618600 ANTIMICROBIAL CUPROUS OXIDE-CONTAINING COATINGS Non-Final OA Vapor Technologies, Inc.
17615559 Polyvalent Dosage Forms and Method For Their Production Non-Final OA DiHeSys Digital Health Systems GmbH
18372209 CELLULOSE DERIVATIVE FREE CAPSULE FOR HERBAL EXTRACTS Non-Final OA GAIA HERBS
18071410 ADHESIVE MATRIX WITH HYDROPHILIC AND HYDROPHOBIC DOMAINS AND A THERAPEUTIC AGENT Final Rejection Corium, LLC
17925515 SLOW-RELEASE MEDICAL PLASTER Non-Final OA FIDIA FARMACEUTICI S.P.A.
17613645 DEVICE AND METHOD FOR DECONTAMINATION/DISINFECTION Final Rejection Aquila Bioscience Limited
17285940 MAMMAL-DERIVED MATRIX AS A SAFE BONE REPLACEMENT Non-Final OA IVORY GRAFT LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month